healthcare
BusinessRetail Investors Buy Novo Dip After Disappointing Weight-Loss Drug Data
TradingStoxx 600 Inches Lower at Start of Christmas Week; Novo Nordisk Surges
Top StoriesIn Weight Loss Battle, Novo and Lilly Face Growing Offensive From Licensed Copies
BusinessNestle Launches Protein Shots for US Weight-Loss Drug Users
Oil, Healthcare Stocks Knock European Shares to Two-Week Lows
Date: December 17, 2024
By Sruthi Shankar (Reuters) -European shares fell to two-week lows on Tuesday, led by energy and healthcare stocks, as investors awaited a slew of major central bank decisions later in the week. The pan-European STOXX 600 index slipped 0.4% by 0924 GMT, trading at its lowest since Dec. 2. Oil and gas stocks dropped 1.2%...
Weight-Loss Drugs Draw Americans Back to the Doctor
Date: December 16, 2024
By Deena Beasley (Reuters) – Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with obesity-related conditions or take the drugs to become eligible for other services, health records and discussions with doctors show. An exclusive analysis of hundreds of thousands of electronic patient records by health data...
Factbox-What Is the UnitedHealthcare Business That Was Led by Slain CEO Brian Thompson?
Date: December 6, 2024
By Michael Erman NEW YORK (Reuters) -Brian Thompson, the CEO of UnitedHealth’s insurance unit, was fatally shot in Midtown Manhattan on Wednesday morning in what police described as a targeted attack by a masked assailant lying in wait just before the parent company’s annual investor conference at a Hilton Hotel. Thompson, 50, had been with...
Sweden’s Eqt Exceeds Investment Targets in India, Doubles Down on Healthcare
Date: December 5, 2024
By Dhwani Pandya MUMBAI (Reuters) – Sweden’s EQT has invested more than its targeted $5 billion in India over the last few years, the head of its Asian business said on Thursday, as the private equity firm focuses on buyouts and investments in the country where it is sees strong deal activity. EQT, with about...
Britain Drug-Cost Watchdog Says It Will Recommend Lilly Obesity Drug
Date: December 5, 2024
By Maggie Fick LONDON (Reuters) – Britain’s drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly’s obesity drug Mounjaro be made available to around 220,000 people in the country via the state health system over the next three years. Mounjaro launched in the UK in February but has been available only for...
More Flexibility Can Keep Sick UK Employees in Work, Report Says
Date: December 5, 2024
By David Milliken LONDON (Reuters) – British employees whose health deteriorates are four times more likely to drop out of the labour market if they have little or no flexibility over their working conditions, according to a report published on Thursday. The Work Foundation, a research group that is part of Lancaster University, said Britain’s...